Market Overview

Esperion Therapeutics (NASDAQ: ESPR)

39.14 -0.22 (-0.56%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/18/19Stifel NicolausMaintainsBuy70.0
9/16/19Goldman SachsUpgradesNeutral45.0
5/29/19Goldman SachsDowngradesSell50.0
4/26/19Goldman SachsUpgradesNeutral
3/13/19JP MorganUpgradesNeutral47.0
12/13/18Goldman SachsInitiates Coverage OnSell45.0
10/16/18BTIG ResearchInitiates Coverage OnBuy82.0
8/17/18CitigroupUpgradesBuy75.0
7/11/18Northland SecuritiesDowngradesMarket Perform
5/04/18Credit SuisseMaintainsOutperform73.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter